TrademarkDir
FARMABIOS
LIVE

Serial Number

79287879

Owner

Farmabios S.p.A.

Attorney

Michael N. Mercanti

Filing Date

Apr 21, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

FARMABIOS Trademark

Serial Number: 79287879 • Registration: 6291623

FARMABIOS is a trademark filed by Farmabios S.p.A. on April 21, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Farmabios S.p.A.

Via Pavia 1

Entity Type: 35

Trademark Details

Filing Date

April 21, 2020

Registration Date

March 16, 2021

Published for Opposition

December 29, 2020

Goods & Services

Anti-inflammatory preparations; cholesterol reducers; steroids; respiratory stimulants; cardiotonic; chemotherapeutics; chemico-pharmaceutical preparations for the treatment of autoimmune disorders, inflammations, asthma, psoriasis, cancer, dermatitis; pharmaceuticals for the treatment of autoimmune disorders, inflammations, asthma, psoriasis, cancer and dermatitis

Analysis and evaluation of product development; scientific analysis in the field of pharmaceuticals, active pharmaceutical ingredients, drug substances; chemistry consultation; consultancy relating to pharmaceutical research and development; product development consultation; consultancy relating to industrial research in the field of active pharmaceutical ingredients and new chemical entities; technical consultancy relating to product development; design and development of industrial products in the field of active pharmaceutical ingredients, drug substances in particular steroids, high potent substances, cannabinoids, antineoplastics; conducting of scientific feasibility studies; conducting of technical feasibility studies in the field of chemical research for the synthesis of existing and new chemical entities; chemical research; research relating to technology; development of new products for others; research and development for others with regard to new products; pharmaceutical research and development; scientific and industrial research in the field of active pharmaceutical ingredients, drug substances in particular steroids, high potent substances, cannabinoids, antineoplastics; laboratory research in the field of chemistry; industrial analysis and research services in the field of chemistry; preparation of scientific reports; preparation of technical reports relating to chemical research for the synthesis of existing and new chemical entities; engineering feasibility studies; development of new technology for others in the field of chemical, pharmaceutical, enzymatic reactions; development of industrial processes for others in the field of chemical, pharmaceutical, enzymatic reactions; development of new industrial products for others

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 16, 2026 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 2, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 2, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 2, 2025 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 21, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 6, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 11, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 22, 2021 FICS
FINAL DISPOSITION PROCESSED
Jun 22, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 16, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 16, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Jan 10, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 29, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 29, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 23, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 23, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 9, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 21, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 21, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 21, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 21, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 21, 2020 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 12, 2020 GNFN
FINAL REFUSAL E-MAILED
Nov 12, 2020 GNFR
FINAL REFUSAL WRITTEN
Nov 12, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 6, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 30, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 30, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 30, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 30, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 30, 2020 COAR
REFUSAL PROCESSED BY IB
Sep 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 5, 2020 RFCS
REFUSAL PROCESSED BY MPU
Aug 24, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 19, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jul 18, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 13, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 23, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 19, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 18, 2020 REPR

Related Trademarks